학술논문

Multi-omics analysis uncovers prognostic biomarkers and tumor ecosystem dynamics during toripalimab combined with nab-paclitaxel and s-1 as neoadjuvant therapy for esophageal squamous carcinoma: A single-center, open-label, single-arm phase 2 trial
Document Type
Journal
Source
CANCER RESEARCH; JUN 15 2022, 82 12, 2p. Supplement: S
Subject
Language
English
ISSN
15387445